Phase I Study of BEBT-209 in Women With Advanced Breast Cancer

NCT06047184 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: BEBT-209 capsules
DRUG: Letrozole tablets
DRUG: Fulvestrant

Sponsor

BeBetter Med Inc

Collaborators

[object Object]
[object Object]